Long-circulating, polyethylene glycol-grafted immunoliposomes

被引:64
作者
Zalipsky, S
Hansen, CB
deMenezes, DEL
Allen, TM
机构
[1] UNIV ALBERTA,DEPT PHARMACOL,EDMONTON,AB T6G 2H7,CANADA
[2] SEQUUS PHARMACEUT INC,MENLO PK,CA 94025
关键词
sterically stabilized liposome; immunoliposome; antibody conjugation; polyethylene glycol; targeted drug delivery;
D O I
10.1016/0168-3659(95)00149-2
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In the last few years a number of advances took place in development of methodologies for preparation of polyethylene glycol (PEG)-grafted immunoliposomes. Several new end-group functionalized PEG lipids were introduced for this purpose. These include pyridyldithiopropionate-PEG- and hydrazide-PEG-PE derivatives, which incorporate well into liposomes and are used for covalent attachment of antibodies to extremities of the liposome-grafted polymeric chains. Methods previously known for linking antibodies to classical liposomes are in some cases applicable to preparation of PEG-grafted immunoliposomes. In these methods antibodies are fixed directly to the lipid bilayer through reactive residues on the polar headgroups of lipids. Attributes of the new methods and their comparison to the traditional methods for preparation of immunoliposomes are the main focus of this manuscript. Particular attention is paid to reactivities, potential and observed complications as well as to the relationship between the conjugation chemistry and biological activity. It is clear that having numerous possible pathways for generating long-circulating immunoliposomes is of great value, since some antibodies tend to be sensitive to different chemical conditions. The current state of the field should facilitate rapid accumulation of in vivo results, which are critical for determination of the true value of this technology.
引用
收藏
页码:153 / 161
页数:9
相关论文
共 32 条
[1]  
Allen Theresa M., 1994, Journal of Liposome Research, V4, P1, DOI 10.3109/08982109409037027
[2]   THE USE OF GLYCOLIPIDS AND HYDROPHILIC POLYMERS IN AVOIDING RAPID UPTAKE OF LIPOSOMES BY THE MONONUCLEAR PHAGOCYTE SYSTEM [J].
ALLEN, TM .
ADVANCED DRUG DELIVERY REVIEWS, 1994, 13 (03) :285-309
[3]   A NEW STRATEGY FOR ATTACHMENT OF ANTIBODIES TO STERICALLY STABILIZED LIPOSOMES RESULTING IN EFFICIENT TARGETING TO CANCER-CELLS [J].
ALLEN, TM ;
BRANDEIS, E ;
HANSEN, CB ;
KAO, GY ;
ZALIPSKY, S .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1995, 1237 (02) :99-108
[4]   LONG-CIRCULATING (STERICALLY STABILIZED) LIPOSOMES FOR TARGETED DRUG-DELIVERY [J].
ALLEN, TM .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (07) :215-220
[5]   LIPOSOMES CONTAINING SYNTHETIC LIPID DERIVATIVES OF POLY(ETHYLENE GLYCOL) SHOW PROLONGED CIRCULATION HALF-LIVES INVIVO [J].
ALLEN, TM ;
HANSEN, C ;
MARTIN, F ;
REDEMANN, C ;
YAUYOUNG, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1066 (01) :29-36
[6]   SPECIFIC TARGETING WITH POLY(ETHYLENE GLYCOL)-MODIFIED LIPOSOMES - COUPLING OF HOMING DEVICES TO THE ENDS OF THE POLYMERIC CHAINS COMBINES EFFECTIVE TARGET BINDING WITH LONG CIRCULATION TIMES [J].
BLUME, G ;
CEVC, G ;
CROMMELIN, MDJA ;
BAKKERWOUDENBERG, IAJM ;
KLUFT, C ;
STORM, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1149 (01) :180-184
[7]   MOLECULAR MECHANISM OF THE LIPID VESICLE LONGEVITY INVIVO [J].
BLUME, G ;
CEVC, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1146 (02) :157-168
[8]  
GABIZON A, 1994, CANCER RES, V54, P987
[9]   PHARMACOKINETICS AND TISSUE DISTRIBUTION OF DOXORUBICIN ENCAPSULATED IN STABLE LIPOSOMES WITH LONG CIRCULATION TIMES [J].
GABIZON, A ;
SHIOTA, R ;
PAPAHADJOPOULOS, D .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (19) :1484-1488
[10]   ATTACHMENT OF ANTIBODIES TO STERICALLY STABILIZED LIPOSOMES - EVALUATION, COMPARISON AND OPTIMIZATION OF COUPLING PROCEDURES [J].
HANSEN, CB ;
KAO, GY ;
MOASE, EH ;
ZALIPSKY, S ;
ALLEN, TM .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1995, 1239 (02) :133-144